Dexell VUR Injectable implant for the treatment of Vesicoureteral Reflux
- Description
Description
Dexell VUR Injectable implant for the treatment of Vesicoureteral Reflux
Vesicoureteral reflux (VUR) is the retrograde passage of urine from the bladder into the upper urinary tract. It is the most common urological diagnosis in children, occurring in approximately 1 % of newborns and as high as 30 to 45% in children with UTI. Additionally, there is a high association between VUR, UTI, hypertension and renal damage.
Treatment Options
Conventional Low Dose Antibiotic Therapy
Extended treatment time
Minimally invasive
Patient-parent non-compliance
Risk of antibiotic resistance
Break through UTI
Surgical Ureter Reimplantation
Reimplantation of ureter into bladder
High success rate
Endoscopic injection of Dextranomer/Hyaluronic Acid Injection
lmmediate correction of VUR
High success rate
Endoscopic correction of VUR offers a minimally invasive, day case procedure with a very low risk of complications compared to open surgery
